Evidence map›Paper›PMID 40553720›Full record

ReviewProgress in cardiovascular diseases

Sudden cardiac arrest: Limitations in risk-stratification and treatment, and the potential for digital technologies and artificial intelligence to improve prediction and outcomes.

Sudarshan Srivats, Fawzi Zghyer, Zaid Shahrori, Christine Albert, Sana M Al-Khatib, Sumeet Chugh, Susan P Etheridge, Zachary D Goldberger, Rakesh Gopinathannair, Dhanunjaya Lakkireddy and 6 more

Abstract readReview
In one paragraph

Review in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sudarshan SrivatsThe Department of Hospital Medicine, Catholic Medical Center, Manchester, NH, USA.
Fawzi ZghyerThe Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
Zaid ShahroriThe Department of Internal Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Christine AlbertDepartment of Cardiology, Smidt Heart Institute, Cedar-Sinai Medical Center, Los Angeles, CA, USA.
Sana M Al-KhatibDivision of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Sumeet ChughCenter for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, and Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Susan P EtheridgePediatric Cardiology, St. Luke's Children's Hospital, Boise, ID, USA; Division of Pediatric Cardiology, Department of Pediatrics, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, USA.
Zachary D GoldbergerDepartment of Medicine, Division of Cardiovascular Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, USA.
Rakesh GopinathannairDepartment of Cardiology/Electrophysiology, Kansas City Heart Rhythm Institute, Overland Park, KS, USA.
Dhanunjaya LakkireddyDepartment of Cardiology/Electrophysiology, Kansas City Heart Rhythm Institute, Overland Park, KS, USA.
Daniel P MorinDepartment of Medicine, Division of Cardiology, University of California San Francisco, San Francisco, CA, USA.
Marco V PerezDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Markus RottmannFeinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, Section of Cardiology, University of Chicago, Chicago, IL, USA.
Jacob E SunshineDepartment of Medicine, Department of Anesthesiology and Pain Medicine, University of Washington, and Paul G Allen School of Computer Science and Engineering, Seattle, WA, USA.
Paul J WangDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mina K ChungThe Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: chungm@ccf.org.

Funding

Project 3 Genes to Omics-Informed Drugs: Drug Repositioning and Testing to Prevent AF ProgressionsP01HL158502 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI Robert Alden Koeth · 2022 to 2026
$16.9M
RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATIONR01HL158071 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BARNARD, JOHN, CHUNG, MINA KAY · 2021 to 2024
$2.9M
NHLBI NIH HHS P01 HL158502NHLBI NIH HHS R01 HL158071
6 · The paper itself

Abstract

Sudden cardiac death (SCD) remains a pervasive public health challenge, accounting for a significant proportion of cardiac and all-cause mortality worldwide. Despite notable advancements in cardiovascular therapies and reductions in overall cardiac mortality, survival following sudden cardiac arrest (SCA) remains dismally low, and prediction strategies remain inadequate. This comprehensive review examines the current landscape of SCD etiologies and the latest guidelines for primary and secondary prevention of SCD with implantable cardioverter defibrillators (ICDs). Particular attention is given to the limitations of left ventricular ejection fraction (LVEF) as the primary tool for risk stratification, given its low sensitivity, specificity, and limited applicability to the broader population in which most SCDs occur. Emerging risk scores and machine learning (ML) driven prediction models have begun to efficiently integrate clinical, electrical, imaging, genetic and laboratory parameters to improve SCD risk stratification. This review highlights examples of such artificial intelligence (AI) prediction models and discusses their potential role in the near-term and long-term prediction of SCD in both in-hospital and out-of-hospital settings, while emphasizing the need for external validation of such models. The review also discusses critical system-level gaps in the chain of survival from cardiac arrest, particularly the need for automated emergency medical services (EMS) activation, community responder engagement, high-quality cardiopulmonary resuscitation (CPR) and improved access to defibrillation. It explores the role of digital technologies such as wearable sensors, smartwatches, smartphone applications and implantable devices in improving real-time SCA detection and enhancing early aspects of the chain of survival from cardiac arrest. Finally, the review calls for a multidisciplinary, multi-sectoral approach including regulatory, technological, and public health stakeholders to bridge gaps in SCD prevention, detection, and response.

Indexed as

Artificial IntelligenceDeath, Sudden, CardiacDecision Support TechniquesDigital TechnologyElectric CountershockPrimary PreventionDefibrillators, ImplantableHumansPredictive Value of TestsRisk AssessmentRisk FactorsTreatment OutcomeArtificial intelligence (AI)Risk stratificationSudden cardiac arrest (SCA)Sudden cardiac death (SCD)Wearable devices

Identifiers

PMID40553720
PMCPMC13158225

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.